Wealth Enhancement Advisory Services LLC Cuts Stake in Colgate-Palmolive Company $CL

Wealth Enhancement Advisory Services LLC cut its holdings in Colgate-Palmolive Company (NYSE:CL) by 16.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 301,550 shares of the company’s stock after selling 57,264 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Colgate-Palmolive were worth $23,281,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CL. S.A. Mason LLC increased its holdings in Colgate-Palmolive by 3.9% during the third quarter. S.A. Mason LLC now owns 3,499 shares of the company’s stock valued at $280,000 after buying an additional 130 shares during the period. Security National Bank of Sioux City Iowa IA lifted its holdings in Colgate-Palmolive by 0.8% during the third quarter. Security National Bank of Sioux City Iowa IA now owns 16,241 shares of the company’s stock worth $1,298,000 after buying an additional 130 shares during the period. Stratos Wealth Advisors LLC boosted its position in Colgate-Palmolive by 4.5% during the 3rd quarter. Stratos Wealth Advisors LLC now owns 3,015 shares of the company’s stock valued at $241,000 after acquiring an additional 130 shares in the last quarter. Chicago Partners Investment Group LLC increased its holdings in shares of Colgate-Palmolive by 1.5% in the 3rd quarter. Chicago Partners Investment Group LLC now owns 9,387 shares of the company’s stock valued at $724,000 after acquiring an additional 136 shares during the period. Finally, Cary Street Partners Investment Advisory LLC lifted its stake in shares of Colgate-Palmolive by 17.7% during the 2nd quarter. Cary Street Partners Investment Advisory LLC now owns 911 shares of the company’s stock worth $83,000 after purchasing an additional 137 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

CL has been the topic of several analyst reports. Royal Bank Of Canada upgraded Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 target price on the stock in a research note on Tuesday, December 9th. Rothschild & Co Redburn set a $93.00 price target on shares of Colgate-Palmolive in a report on Friday, February 13th. Wells Fargo & Company boosted their price objective on shares of Colgate-Palmolive from $86.00 to $94.00 and gave the stock an “equal weight” rating in a research note on Sunday, February 1st. TD Cowen reissued a “buy” rating on shares of Colgate-Palmolive in a research report on Monday, February 2nd. Finally, Argus restated a “hold” rating on shares of Colgate-Palmolive in a research note on Thursday, December 11th. Eleven research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $94.75.

Colgate-Palmolive Stock Down 0.8%

NYSE:CL opened at $84.46 on Wednesday. The company has a current ratio of 0.83, a quick ratio of 0.54 and a debt-to-equity ratio of 18.82. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $99.33. The company has a market cap of $68.08 billion, a PE ratio of 32.24, a P/E/G ratio of 3.81 and a beta of 0.28. The company’s 50 day moving average is $91.10 and its two-hundred day moving average is $83.36.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. The business had revenue of $5.23 billion during the quarter, compared to analysts’ expectations of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The business’s quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter last year, the company posted $0.91 earnings per share. Analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Monday, April 20th will be paid a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a yield of 2.5%. The ex-dividend date is Monday, April 20th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 79.39%.

Insider Transactions at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 97,843 shares of Colgate-Palmolive stock in a transaction dated Wednesday, February 4th. The stock was sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the completion of the sale, the chief financial officer owned 55,310 shares of the company’s stock, valued at $5,214,073.70. The trade was a 63.89% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Panagiotis Tsourapas sold 35,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $94.61, for a total transaction of $3,311,350.00. Following the transaction, the chief operating officer directly owned 10,415 shares of the company’s stock, valued at $985,363.15. This represents a 77.07% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 184,683 shares of company stock valued at $17,486,693. 0.41% of the stock is owned by company insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.